Belite Bio (BLTE) CEO Lin Yu‑Hsin Sells 365 Shares

What Happened

Lin Yu‑Hsin, CEO of Belite Bio, sold a total of 365 American Depositary Shares (ADSs) in two open‑market transactions on August 12, 2026. The sales were: 142 shares at $180.00 each for $25,560, and 223 shares at $180.57 each for $40,267, for a combined proceeds of approximately $65,827. This was a sale (routine liquidation), not a purchase.

Key Details

• Transaction dates: August 12, 2026 (reported on Form 4 filed August 14, 2026).
• Prices and amounts: 142 @ $180.00 = $25,560; 223 @ $180.57 = $40,267; total ≈ $65,827.
• Shares owned after transaction: not specified in the provided filing extract.
• Footnotes:
  • F1: Each ADS represents one ordinary share of the issuer.
  • F2: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted by the insider on 12/23/2025.
• Timeliness: Filing appears timely (transaction 8/12/2026; Form 4 filed 8/14/2026).

Context

Sales executed under a prearranged 10b5‑1 plan are typically scheduled in advance and are often routine liquidity events rather than immediate signals about company prospects. As this is a sale (not a purchase), it should be viewed as insider liquidity rather than direct evidence of confidence or concern about Belite Bio’s outlook.